Skip to main content
. 2011 Oct 25;3(4):3972–3990. doi: 10.3390/cancers3043972

Figure 3.

Figure 3.

In a 4-year-old medulloblastoma patient, CSI delivered with HT, compared to conventional techniques, is able to give a more homogeneous dose and better conform the dose to the target, but with a larger low dose bath.